<DOC>
	<DOCNO>NCT02180087</DOCNO>
	<brief_summary>Currently , management pain cardiac surgery base concept multimodal analgesia : Combined use non-opioid analgesic associate morphine intravenous analgesia system control patient ( patient-controlled analgesia-PCA ) . The combination paracetamol morphine PCA effective pain rest , limit pain mobilization cause problem side effect associate opioid ( overdose , sedation , respiratory depression , gastrointestinal intolerance , urinary retention ... ) contribute factor increase length stay Intensive Care Unit , additional cost care increase postoperative morbidity mortality . Methods prove effectiveness pain mobilization use postoperative cardiac surgery : anti-inflammatory drug ( NSAIDs ) / loco-regional analgesia technique . NSAIDs enhance analgesia produce PCA Morphine allow reduction morphine consumption , improve postoperative pain , decrease sedation decrease postoperative morbidity mortality . Adverse effect NSAIDs commensurate time exposure dose . Consequently , NSAIDs , absence against-indications , always prescribe use lowest effective dose short possible time . Some study suggest low dos NSAIDs n't appear affect effectiveness . At present , investigator study address hypothesis minimum dose ketoprofen analgesic effect obtain . The investigator hypothesis low dose ketoprofen may efficacy pain postoperative mobilization cardiac surgery . The investigator want find , study , `` optimal '' ketoprofen dose would minimum dose clinical efficacy demonstrate dose . This optimal dose could reduce number adverse effect NSAIDs , study probably enough power prove . NSAID use low dos , postoperative cardiac surgery , could extend patient population risk duration longer 48 hour .</brief_summary>
	<brief_title>Reduce Nonsteroidal Antiinflammatory Drugs Doses Analgesia After Sternotomy</brief_title>
	<detailed_description>To answer hypothesis investigator consider start study four group patient appropriate dos patient weight gradually increase ketoprofen use seek minimum effective dose . Four group determine randomization . In group , analgesia supplement systematic standard self-administered treatment morphine paracetamol . - Group 1 : Placebo group ( P ) . 0 mg/kg ketoprofen IV every 6 hour 48 hour ( 0 mg/kg every 24 hour ) 48 hour . - Group 2 : `` Ketoprofen quarter dose '' ( K ¼ ) . 0,125 mg/kg ketoprofen IV every 6 hour ( 0,5 mg/kg every 24 hour ) 48 hour . - Group 3 : `` Ketoprofen half-dose '' ( K ½ ) . 0,25 mg/kg ketoprofen IV every 6 hour ( 1 mg/kg every 24 hour ) 48 hour . - Group 4 : `` Ketoprofen full dose '' ( KPD ) . 0,5 mg/kg ketoprofen IV every 6 hour ( 2 mg/kg every 24 hour ) 48 hour .</detailed_description>
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Ketoprofen</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<criteria>Patients schedule cardiac surgery ( Coronary artery bypass graft , valve replacement ) Age 18 year Weight 60 100 kg Absence criterion noninclusion Age 75 year Renal insufficiency ( MDRD &lt; 60 ml / min ) Hepatic Insufficiency Congestive heart failure ( EF &lt; 40 % ) Insulinrequiring diabetes Preoperative coagulation trouble History peptic ulcer gastrointestinal bleeding Allergy NSAIDs Surgery emergency , aorta surgery , heart transplantation Peptic ulcer scalable , history peptic ulcer recurrent bleeding ( 2 distinct episode bleed ulceration objectify ) Pregnant lactate woman Major protect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Cardiac surgery</keyword>
	<keyword>Post-operative pain</keyword>
	<keyword>Kétoprofène</keyword>
	<keyword>Minimum analgesic dose</keyword>
	<keyword>Morphin consumption</keyword>
	<keyword>Morphin secondary effect</keyword>
	<keyword>Patient comfort satisfaction</keyword>
	<keyword>Renal fonction</keyword>
</DOC>